Zydus Wellness Ltd - 531335 - Compliance Under Regulation 33 Of SEBI Listing Regulations, 2015
Compliance Under Regulation 33 Of SEBI Listing Regulations, 201508-04-2021
Zydus Wellness Ltd - 531335 - Compliance Under Regulation 33 Of SEBI Listing Regulations, 2015
Compliance Under Regulation 33 Of SEBI Listing Regulations, 2015Remdesivir output to be ramped up as Covid-19 cases rise sharply
Zydus had recently also slashed prices of its remdesivir brand Remdac to Rs 899 per doseZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg 74(5) of SEBI DP Regulations.Zydus Wellness Ltd - 531335 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dhanraj DagarDesignation :- Company Secretary and Compliance OfficerZydus Wellness Ltd - 531335 - Shareholding for the Period Ended March 31, 2021
Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click hereZydus seeks DCGI nod for add'l indication of Hep C drug in Covid-19 therapy
In a likely breakthrough, interim results indicate that PegIFN when administered early on, could help patients recover faster and avoid complications seen in advanced Covid stagesZydus Wellness Ltd - 531335 - Compliance Certificate Under Regulation 7(3) By RTA And Company.
Compliance Certificate under Regulation 7(3) by RTA and Company.Zydus Wellness Ltd - 531335 - Large Corporate Entity Disclosure.
Large Corporate Entity Disclosure.Zydus Wellness Ltd - 531335 - Closure of Trading Window
Intimation of Trading Window Closure.Zydus slashes COVID-19 drug Remdesivir price by over two-third; now costs Rs 899
This move to further revise the prices will go a long way in helping patients during these critical times, the company said.